catalyst · primary record
GILOTRIF
Patent expiry · 2026-11-09 · AFATINIB DIMALEATE
| Company | BOEHRINGER INGELHEIM |
|---|---|
| Ticker | Not stated |
| Impact | high |
| Detail | US 9539258 expires · AFATINIB DIMALEATE |
| Source | FDA Orange Book |
Provenance
- Source: FDA Orange Book
- Fetched at: 2026-11-02T01:51:39.144Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: BOEHRINGER INGELHEIM:GILOTRIF:2026-11-09:US 9539258 expires · AFATINIB DIMALEATE
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.